1
Clinical Trials associated with MVF-HER-2 (597-626) Vaccine(Indiana University)Phase Ib Active Immunotherapy Trial (Expansion) With a Combination of Two Chimeric (Trastuzumab-like and Pertuzumab-like) HER-2 B Cell Peptide Vaccine Emulsified in ISA 51 Adjuvant in Patients With Advanced Solid Tumors
This phase I trial studies the side effects and best dose of vaccine therapy in treating patients with metastatic solid tumors. Vaccines made from antibodies and peptides combined with tumor cells may help the body build an effective immune response to kill tumor cells.
100 Clinical Results associated with MVF-HER-2 (597-626) Vaccine(Indiana University)
100 Translational Medicine associated with MVF-HER-2 (597-626) Vaccine(Indiana University)
100 Patents (Medical) associated with MVF-HER-2 (597-626) Vaccine(Indiana University)
100 Deals associated with MVF-HER-2 (597-626) Vaccine(Indiana University)